Abstract
This chapter covers the current gold standard for evaluating the effectiveness of therapeutic interventions, the randomized controlled trial (RCT). Key features of the RCT, regardless of sub-type, are randomization, allocation concealment, and blinding. These key features help reduce bias and the influence of confounding variables, making the randomized controlled trial eminently suitable to determine cause and effect relationships. Protocol design and registration prior to trial onset are important factors in determining the quality of the trial, and various trial design sub-types, including parallel, factorial, crossover, and cluster, are outlined and the strengths and weakness of each examined. Various checklists such as SPIRIT and CONSORT can be used to ensure proper reporting of both trial protocols and trial findings, to ensure clear, concise reporting. Finally, the shortcomings of RCTs and newer trial designs, such as comparative effectiveness research and pragmatic studies, designed to overcome some of these issues are examined, and ways to make clinical trial results more clinically applicable are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Altman DG, Bland JM. How to randomise. BMJ. 1999a;319(7211):703–4.
Altman DG, Bland JM. Statistics notes. Treatment allocation in controlled trials: why randomise? BMJ. 1999b;318(7192):1209.
Arnold DM, Burns KEA, Adhikari NKJ, Kho ME, Meade MO, Cook DJ. The design and interpretation of pilot trials in clinical research in critical care. Crit Care Med. 2009;37(1 Suppl):S69–74.
Barr K, Smith CA, de Lacey SL. Participation in a randomised controlled trial of acupuncture as an adjunct to in vitro fertilisation: the views of study patients and acupuncturists. Eur J Integr Med. 2016;8(1):48–54. https://doi.org/10.1016/j.eujim.2015.10.006.
Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K,... Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3): 200–7. https://doi.org/10.7326/0003-4819-158-3-201302050-00583.
Committee for Proprietary Medicinal Products. Points to consider on switching between superiority and non-inferiority. Br J Clin Pharmacol. 2001;52(3):223–8.
Community Intervention Trial for Smoking Cessation (COMMIT): I. cohort results from a four-year community intervention. Am J Public Health. 1995;85(2): 183–92.
Cornfield J. Randomization by group: a formal analysis. Am J Epidemiol. 1978;108(2):100–2.
De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R,... International Committee of Medical Journal, E. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med. 2004;351(12): 1250–1. https://doi.org/10.1056/NEJMe048225.
Doherty S. History of evidence-based medicine. Oranges, chloride of lime and leeches: barriers to teaching old dogs new tricks. Emerg Med Australas. 2005;17(4):314–21.
Doig GS, Simpson F. Randomization and allocation concealment: a practical guide for researchers. J Crit Care. 2005;20(2):187–91.; discussion 191–83. https://doi.org/10.1016/j.jcrc.2005.04.005.
Doll R. Controlled trials: the 1948 watershed. BMJ. 1998;317(7167): 1217–20.
Donner A, Klar N. Pitfalls of and controversies in cluster randomization trials. Am J Public Health. 2004;94(3):416–22.
Fanelli D. Do pressures to publish increase scientists’ bias? An empirical support from US states data. PLoS One. 2010;5(4):e10271. https://doi.org/10.1371/journal.pone.0010271.
Feeley N, Cossette S, Cote J, Heon M, Stremler R, Martorella G, Purden M. The importance of piloting an RCT intervention. Can J Nurs Res. 2009;41(2):85–99.
Ganju J, Rom D. Non-inferiority versus superiority drug claims: the (not so) subtle distinction. Trials. 2017;18(1):278. https://doi.org/10.1186/s13063-017-2024-2.
Gartlehner G, Hansen R, Nissman D, Lodhr K, Carey T. Criteria for distinguishing effectiveness from efficacy in systematic reviews. 2006. Retrieved from.
Gluud LL. Bias in clinical intervention research. Am J Epidemiol. 2006;163(6):493–501. https://doi.org/10.1093/aje/kwj069.
Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD,... Sterne JA. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343: d5928. https://doi.org/10.1136/bmj.d5928.
Hill AB. The clinical trial. N Engl J Med. 1952;247(4):113–9. https://doi.org/10.1056/nejm195207242470401.
Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999;319(7211):670–4.
ICH. ICH harmonised tripartite guideline. Guideline for Good Clinical Practice E6(R1) 1996.
Jairath N, Hogerney M, Parsons C. The role of the pilot study: a case illustration from cardiac nursing research. Appl Nurs Res. 2000;13(2):92–6.
Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ. 2001;323(7303):42–6.
Kalish LA, Begg CB. Treatment allocation methods in clinical trials: a review. Stat Med. 1985;4(2):129–44.
Katz MH. Study design and statistical analysis: a practical guide for clinicians. Cambridge: Cambridge University Press; 2006.
Landorf KB. Clinical trials: the good, the bad and the ugly. In: Liamputtong P, editor. Research methods in health: foundations for evidence-based practice. 3rd ed. Melbourne: Oxford University Press; 2017. p. 275–90.
Lesaffre E. Superiority, equivalence, and non-inferiority trials. Bull NYU Hosp Jt Dis. 2008;66(2):150–4.
Manchikanti L. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations. Pain Physician. 2008;11(2):161–86.
Mayer D. Essential evidence-based medicine. Cambridge: Cambridge University Press; 2004.
Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001;134(8):657–62.
Moher D, Hopewell S, Schulz K.F, Montori V, Gotzsche PC, Devereaux PJ,.... Consort. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg (Lond). 2012;10(1): 28–55.
Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ, Group C. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA. 2006;295(10):1152–60. https://doi.org/10.1001/jama.295.10.1152.
Sackett DL. Bias in analytic research. J Chronic Dis. 1979;32(1–2):51–63.
Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273(5):408–12.
Scott A, Rucklidge JJ, Mulder RT. Is mandatory prospective trial registration working to prevent publication of unregistered trials and selective outcome reporting? An observational study of five psychiatry journals that mandate prospective clinical trial registration. PLoS One. 2015;10(8):e0133718. https://doi.org/10.1371/journal.pone.0133718.
Suresh KP. An overview of randomization techniques: an unbiased assessment of outcome in clinical research. J Hum Reprod Sci. 2011;4(1):8–11. https://doi.org/10.4103/0974-1208.82352.
The CONSORT Statement. The CONSORT statement. 2017. Retrieved from http://www.consort-statement.org/
The James Lind Library. Avoiding biased comparisons. 2007a. Retrieved from http://www.jameslindlibrary.org/essays/bias/avoiding-biased-comparisons.html
The James Lind Library. Differences in the way treatment outcomes are assessed. 2007b. Retrieved from www.jameslind.org
The James Lind Library. Taking account of the play of chance. 2007c. 17 Dec 2009. Retrieved from www.jameslind.org
Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG,... Chalkidou K. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol. 2009;62(5): 464–75. https://doi.org/10.1016/j.jclinepi.2008.12.011.
Viboud C, Boelle PY, Kelly J, Auquier A, Schlingmann J, Roujeau JC, Flahault A. Comparison of the statistical efficiency of case-crossover and case-control designs: application to severe cutaneous adverse reactions. J Clin Epidemiol. 2001;54(12):1218–27.
Witt CM, Aickin M, Baca T, Cherkin D, Haan MN, Hammerschlag R.,... Berman BM. Effectiveness Guidance Document (EGD) for acupuncture research – a consensus document for conducting trials. BMC Complement Altern Med. 2012;12:148. https://doi.org/10.1186/1472-6882-12-148.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Armour, M., Ee, C., Steiner, G.Z. (2019). Randomized Controlled Trials. In: Liamputtong, P. (eds) Handbook of Research Methods in Health Social Sciences. Springer, Singapore. https://doi.org/10.1007/978-981-10-5251-4_94
Download citation
DOI: https://doi.org/10.1007/978-981-10-5251-4_94
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-5250-7
Online ISBN: 978-981-10-5251-4
eBook Packages: Social SciencesReference Module Humanities and Social SciencesReference Module Business, Economics and Social Sciences